Genpact Limited Stock Performance
| G Stock | USD 46.19 0.37 0.81% |
On a scale of 0 to 100, Genpact holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 0.85, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genpact's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genpact is expected to be smaller as well. Please check Genpact's total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Genpact's current trending patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Genpact Limited are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Genpact reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.81 | Five Day Return 2.87 | Year To Date Return 32.81 | Ten Year Return 158.77 | All Time Return 175.76 |
Forward Dividend Yield 0.0132 | Payout Ratio 0.196 | Forward Dividend Rate 0.61 | Dividend Date 2024-12-23 | Ex Dividend Date 2024-12-09 |
| Genpact dividend paid on 25th of September 2024 | 09/25/2024 |
1 | Should Value Investors Buy Genpact Stock | 09/26/2024 |
2 | Will Genpact Beat Estimates Again in Its Next Earnings Report | 10/18/2024 |
3 | Genpact Q3 Earnings Snapshot | 11/07/2024 |
4 | Robert W. Baird Boosts Genpact Price Target to 48.00 | 11/12/2024 |
5 | Genpact Named a Leader in Avasants 2024 Insurance Business Process Transformation RadarView Report | 11/13/2024 |
6 | Insider Sale Director Carol Lindstrom Sells Shares of Genpact Ltd | 11/15/2024 |
7 | Genpact Named to Forbes Worlds Best Employers 2024 List for Fourth Consecutive Year | 11/18/2024 |
8 | Is Genpact Stock Undervalued Right Now | 11/19/2024 |
9 | Genpact Recognized as a Leader in Procurement Outsourcing Services in the 2024 Everest Group PEAK Matrix Assessment | 11/20/2024 |
10 | Genpact extends partnership with Ferring Pharmaceuticals G | 11/21/2024 |
| Begin Period Cash Flow | 646.8 M |
Genpact |
Genpact Relative Risk vs. Return Landscape
If you would invest 3,930 in Genpact Limited on August 27, 2024 and sell it today you would earn a total of 689.00 from holding Genpact Limited or generate 17.53% return on investment over 90 days. Genpact Limited is generating 0.266% of daily returns and assumes 1.6693% volatility on return distribution over the 90 days horizon. Put is differently, 14% of stocks are less volatile than Genpact, and over 95% of all traded equities are expected to make higher returns on investment over the next 90 days. Expected Return |
| Risk |
Genpact Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genpact's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genpact Limited, and traders can use it to determine the average amount a Genpact's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1593
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | G | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.67 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Genpact is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genpact by adding it to a well-diversified portfolio.
Genpact Fundamentals Growth
Genpact Stock prices reflect investors' perceptions of the future prospects and financial health of Genpact, and Genpact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genpact Stock performance.
| Return On Equity | 0.3 | ||||
| Return On Asset | 0.0846 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 8.98 B | ||||
| Shares Outstanding | 176.36 M | ||||
| Price To Earning | 28.59 X | ||||
| Price To Book | 3.40 X | ||||
| Price To Sales | 1.75 X | ||||
| Revenue | 4.48 B | ||||
| Gross Profit | 1.54 B | ||||
| EBITDA | 630.86 M | ||||
| Net Income | 631.25 M | ||||
| Cash And Equivalents | 646.76 M | ||||
| Cash Per Share | 2.53 X | ||||
| Total Debt | 1.5 B | ||||
| Debt To Equity | 1.04 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 13.58 X | ||||
| Cash Flow From Operations | 490.81 M | ||||
| Earnings Per Share | 3.64 X | ||||
| Market Capitalization | 8.15 B | ||||
| Total Asset | 4.81 B | ||||
| Retained Earnings | 1.09 B | ||||
| Working Capital | 573.58 M | ||||
| Current Asset | 1.2 B | ||||
| Current Liabilities | 594.48 M | ||||
About Genpact Performance
By analyzing Genpact's fundamental ratios, stakeholders can gain valuable insights into Genpact's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genpact has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genpact has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.21 | 0.22 | |
| Return On Capital Employed | 0.18 | 0.10 | |
| Return On Assets | 0.13 | 0.14 | |
| Return On Equity | 0.28 | 0.29 |
Things to note about Genpact Limited performance evaluation
Checking the ongoing alerts about Genpact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genpact Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genpact Limited is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from thefly.com: Genpact extends partnership with Ferring Pharmaceuticals G |
- Analyzing Genpact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genpact's stock is overvalued or undervalued compared to its peers.
- Examining Genpact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genpact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genpact's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genpact's stock. These opinions can provide insight into Genpact's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |